FDA 483 - SEAGEN INC. - May 13, 2025

SEAGEN INC., a drug intermediate manufacturer in Bothell, WA, was cited for inadequate training and qualification processes for operators performing aseptic filling of PADCEV mAb intermediate. The firm's procedures failed to ensure initial proficiency and lacked periodic re-qualification for these critical aseptic operations.